Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab
Blood - United States
doi 10.1182/blood-2018-08-870238
Full Text
Open PDFAbstract
Available in full text
Date
May 9, 2019
Authors
Publisher
American Society of Hematology